Table 3 Patients’ characteristics according to high or low levels of early (HbA1c) or end (fluorescent AGE) glycation products, considering median as cut off point
AGE | HbA1c | |||||
|---|---|---|---|---|---|---|
HIGH | LOW | p | HIGH | LOW | p | |
Demographic data | ||||||
Age (years) | 62.7 ± 14.7 | 62.9 ± 11.7 | 0.913 | 67.5 ± 12.5 | 58.1 ± 12.7 | 0.001 |
Female, % | 22.9 | 26.5 | 0.560 | 28.9 | 21.5 | 0.272 |
Medical history | ||||||
BMI (Kg/m2) | 27.1 ± 3.6 | 26.9 ± 3.6 | 0.839 | 27.6 ± 4.0 | 26.2 ± 3.0 | 0.020 |
Current smoking, % | 39.6 | 29.6 | 0.290 | 24.4 | 39.2 | 0.116 |
Diabetes, % | 28.1 | 25.5 | 0.681 | 43.3 | 11.4 | 0.001 |
Hypertensión, % | 55.2 | 40.8 | 0.045 | 60.0 | 35.4 | 0.001 |
Dyslipemia, % | 51.0 | 38.0 | 0.086 | 51.1 | 32.9 | 0.017 |
On admission data | ||||||
STEMI, % | 45.8 | 58.2 | 0.086 | 48.9 | 53.2 | 0.579 |
Killip class ≥ II, % | 11.5 | 16.3 | 0.327 | 18.9 | 8.9 | 0.062 |
Systolic blood pressure (mmHg) | 137.9 ± 25.1 | 136.0 ± 27.8 | 0.603 | 141.2 ± 29.2 | 133.3 ± 22.2 | 0.050 |
Heart rate (bpm) | 74.7 ± 18.3 | 75.7 ± 19.4 | 0.714 | 78.1 ± 19.8 | 72.2 ± 16.0 | 0.035 |
Atrial fibrillation, % | 7.3 | 9.2 | 0.632 | 13.3 | 5.1 | 0.067 |
Haemoglobin (g/dL) | 14.3 ± 1.8 | 14.4 ± 1.4 | 0.829 | 14.1 ± 1.7 | 14.5 ± 1.4 | 0.104 |
Leukocytes (103/μL) | 10.6 ± 3.8 | 10.9 ± 4.1 | 0.622 | 10.5 ± 3.8 | 10.9 ± 4.1 | 0.453 |
Creatinine (mg/dL) | 0.97 ± 0.15 | 0.93 ± 0.17 | 0.126 | 0.96 ± 0.15 | 0.94 ± 0.16 | 0.418 |
Laboratory parameters | ||||||
TPI peak (ng/dL) | 13.9 (6.4-70.1) | 22.2 (4.5-69.4) | 0.700 | 17.3 (6.2-85.6) | 17.0 (5.1-63.2) | 0.649 |
NT-proBNP (pg/mL) | 783.0 (342.0-1712.7) | 826.0 (376.5-1780.7) | 0.348 | 1173.0 (450.2-2376.5) | 568.5 (225.8-1235.2) | 0.128 |
On admission data | ||||||
STEMI, % | 15.6 | 23.5 | 0.169 | 23.3 | 15.2 | 0.183 |
Killip class ≥ II, % | 58.3 | 45.9 | 0.084 | 61.1 | 39.2 | 0.005 |